Effective intra-arterial chemotherapy for acinar cell carcinoma of the pancreas

Digestive Surgery

Volumn 16, Issue 1, 1999, Pages 76-79

  Ukei, Toshisada ^a,c   Okagawa, Kazuhiro ^a   Uemura, Yoshio ^a   Miyauchi, Keisuke ^a   Kaneko, Tadashi ^a   Mizunoya, Sumio ^a   Monden, Morito ^b  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

Author keywords

Acinar cell carcinoma; Arthritis; Eosinophilia; Intra arterial chemotherapy; Metastatic liver tumor; Pancreas

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

ACINAR CELL CARCINOMA; ADULT; ARTICLE; CANCER SURVIVAL; CASE REPORT; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER METASTASIS; MALE; PANCREATICODUODENECTOMY; PREOPERATIVE TREATMENT; SEPSIS; TUMOR VOLUME;

ADULT; ANGIOGRAPHY; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ACINAR CELL; CISPLATIN; COMBINED MODALITY THERAPY; FATAL OUTCOME; FLUOROURACIL; HUMANS; INJECTIONS, INTRA-ARTERIAL; MALE; MITOMYCINS; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0033040513     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018698     Document Type: Article

References (13)

1. Jie Chen, Baithun SI: Morphological study of 391 cases of exocrine pancreatic tumors with special reference to the classification of exocrine pancreatic carcinoma. J Pathol 1985;146: 17-29.
2. Carter S, Comis R: The integration of chemotherapy into combine modality approach for cancer treatment. VI. Pancreatic adenocarcinoma. Cancer Treat Rev 1975;2:193-214.
3. Schein P, Lavin P, Moertel C, et al: Randomized phase II clinical trial of adriamycin, methotrexate and actinomycin D in advanced measurable pancreatic carcinoma. Cancer 1978;42:19-22.
4. Zimmermann SE, Smith FP, Schein PS: Chemotherapy of pancreatic carcinoma. Cancer 1981;47:1724-1728.
5. Smith FP, Hoth DF, Levin B, et al: 5-Fluorouracil, adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas. Cancer 1980;46:2014-2018.
6. Yokoyama T, Shimada Y: Chemotherapy for advanced pancreatic carcinoma. Jpn J Cancer Chemother 1992;19:2338-2343.
7. Oster M, Gray R, Panasci L, et al: Chemotherapy for advanced pancreatic cancer. Cancer 1986;57:29-33.
8. Gastrointestinal Tumor Study Group: Phase II studies of drug combinations in advanced pancreatic carcinoma: Fluorouracil plus doxorubicin plus mitomycin-C and two regimens of streptozotocin plus mitomycin-C plus fluorouracil. J Clin Oncol 1986;4:1794-1798.
9. Rothman H, Cantrell JE Jr, Lokich J, et al: Continuous infusion 5-fluorouracil plus weekly cisplatin for pancreatic carcinoma. Cancer 1991;68:264-268.
10. Gastrointestinal Tumor Study Group: A phase II study of combined 5-fluorouracil, doxorubicin, and cisplatin in the treatment of advanced upper gastrointestinal adenocarcinomas. J Clin Oncol 1986;4:1053-1057.
11. Kunimura T, Morohoshi T, Sato M, et al: Histological evaluation of intra-arterial infusion and systemic chemotherapy for pancreatic carcinomas. Jpn J Cancer Chemother 1992;19: 355-360.
12. Robertson JC, Eeles GH: Syndrome associated with pancreatic acinar cell carcinoma. Br Med J 1970;ii:708-709.
13. Osborne RR: Functioning acinous cell carcinoma of the pancreas accompanied with widespread focal fat necrosis. Arch Intern Med 1950;85:933-943.